Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Traumatic Brain Injury Excellence Forum

Traumatic Brain Injury
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Sports Concussion Research: What’s in the Pipeline?
Videos
Sports Concussion Research: What’s in the Pipeline?
11/20/2020
In this video, Christina L. Master, MD, reviews areas of research that have grown significantly over the past year, including earlier interventions with active management and characterizing concussion profiles, and how they may impact...
In this video, Christina L. Master, MD, reviews areas of research that have grown significantly over the past year, including earlier interventions with active management and characterizing concussion profiles, and how they may impact...
In this video, Christina L....
11/20/2020
Neurology
Advances in Diagnostic and Treatment Research in Sports Concussion
Videos
Advances in Diagnostic and Treatment Research in Sports Concussion
11/02/2020
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L....
11/02/2020
Neurology
Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
Videos
Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
10/23/2020
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L....
10/23/2020
Neurology
John Leddy, MD, on Returning to Exercise After Concussion
Podcasts
John Leddy, MD, on Returning to Exercise After Concussion
09/08/2020
He discusses important considerations for returning to exercise post-concussion, explains common pitfalls in the diagnosis and treatment of sports-related concussion, and addresses treating acute sports-related concussion via early testing...
He discusses important considerations for returning to exercise post-concussion, explains common pitfalls in the diagnosis and treatment of sports-related concussion, and addresses treating acute sports-related concussion via early testing...
He discusses important...
09/08/2020
Neurology
Important Research Advances in the Clinical Science of Concussion
Videos
Important Research Advances in the Clinical Science of Concussion
09/05/2020
In this video, Christina L. Master, MD, discusses recently published research on disparities in sports concussion when it comes to availability of flag football vs tackle football, the impact of active specialized sports medicine care vs a...
In this video, Christina L. Master, MD, discusses recently published research on disparities in sports concussion when it comes to availability of flag football vs tackle football, the impact of active specialized sports medicine care vs a...
In this video, Christina L....
09/05/2020
Neurology
5 Questions About the Long-Term Impact of Severe TBI Among Older Adults
Q&As
5 Questions About the Long-Term Impact of Severe TBI Among Older Adults
03/25/2020
More adults aged 65 years or older are experiencing severe traumatic brain injury (TBI), and results of a new study show that these patients’ risk of mortality and severe morbidity is high. Lead study author Matthew J. Maiden, PhD, answered...
More adults aged 65 years or older are experiencing severe traumatic brain injury (TBI), and results of a new study show that these patients’ risk of mortality and severe morbidity is high. Lead study author Matthew J. Maiden, PhD, answered...
More adults aged 65 years or...
03/25/2020
Neurology
Julian Bailes, MD, on Everything You Need to Know About TBI
Podcasts
Julian Bailes, MD, on Everything You Need to Know About TBI
03/05/2020
In this podcast, Julian Bailes, MD, from NorthShore University HealthSystem, discusses traumatic brain injury, including mild traumatic brain injury and chronic traumatic encephalopathy.
In this podcast, Julian Bailes, MD, from NorthShore University HealthSystem, discusses traumatic brain injury, including mild traumatic brain injury and chronic traumatic encephalopathy.
In this podcast, Julian Bailes,...
03/05/2020
Neurology
5 Questions About the Challenges of Diagnosing mTBI in Youth
Q&As
5 Questions About the Challenges of Diagnosing mTBI in Youth
03/03/2020
Traumatic brain injury affects people of all ages, but children are at high risk especially if they participate in sports. Nicole D. Reams, MD, a sports neurologist at NorthShore University HealthSystem, answers our questions about the...
Traumatic brain injury affects people of all ages, but children are at high risk especially if they participate in sports. Nicole D. Reams, MD, a sports neurologist at NorthShore University HealthSystem, answers our questions about the...
Traumatic brain injury affects...
03/03/2020
Neurology
Q&As
5 Questions About Returning to Play After a Sports-Related Concussion
10/19/2019
John Leddy, MD, from the University at Buffalo, answers our questions about returning to play after a sports-related concussion, a topic he also spoke about at the American Academy of Neurology’s Sports Concussion Conference.
John Leddy, MD, from the University at Buffalo, answers our questions about returning to play after a sports-related concussion, a topic he also spoke about at the American Academy of Neurology’s Sports Concussion Conference.
John Leddy, MD, from the...
10/19/2019
Neurology
Q&As
4 Questions About Molecular, Cellular, and Circuit Mechanisms of Cognitive Enhancement
09/16/2019
Alcino Silva, PhD, answers our questions about molecular memory systems and how they relate to neurological diseases—a topic that he will also discuss at the American Neurological Association’s Annual Meeting.
Alcino Silva, PhD, answers our questions about molecular memory systems and how they relate to neurological diseases—a topic that he will also discuss at the American Neurological Association’s Annual Meeting.
Alcino Silva, PhD, answers our...
09/16/2019
Neurology

Advertisement

Advertisement

News

Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement